Literature DB >> 11433530

Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma.

G Li1, N Hu, A M Goldstein, Z Z Tang, M J Roth, Q H Wang, S M Dawsey, X Y Han, T Ding, J Huang, C Giffen, P R Taylor, M R Emmert-Buck.   

Abstract

Allelic loss on chromosome 13 occurs frequently in esophageal squamous cell carcinoma. However, studies of the two known tumor suppressor genes located on 13q, RB1 and BRCA2, have shown few mutations, suggesting that other genes are likely to be involved in the development of this tumor type. To identify a minimal deletion interval, we first analyzed 42 microsatellite markers spanning chromosome bands 13q11-q13 in 56 esophageal squamous cell carcinoma patients, including 34 with a family history of upper gastrointestinal cancer and 22 without a family history of cancer. Lifestyle risk factors and clinical/pathologic characteristics were also collected. Two commonly deleted regions were identified: one was located on band 13q12.11, between markers D13S787 and D13S221; the other was located on bands 13q12.3-q13.1 from markers D13S267 to D13S219. We observed higher allelic loss frequencies for eight of the microsatellite markers in those patients with a family history of upper gastrointestinal cancer compared to patients without such a history. This study suggests that one or more unidentified tumor suppressor genes are located on chromosome arm 13q that play a role in the development of esophageal squamous cell carcinoma. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11433530     DOI: 10.1002/gcc.1158

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons.

Authors:  Mark J Roth; Wen-Qiang Wei; Jessica Baer; Christian C Abnet; Guo-Qing Wang; Lawrence R Sternberg; Andrew C Warner; Laura Lee Johnson; Ning Lu; Carol A Giffen; Sanford M Dawsey; You-Lin Qiao; James Cherry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

3.  Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.

Authors:  Nan Hu; Robert J Clifford; Howard H Yang; Chaoyu Wang; Alisa M Goldstein; Ti Ding; Philip R Taylor; Maxwell P Lee
Journal:  BMC Genomics       Date:  2010-10-18       Impact factor: 3.969

4.  Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients.

Authors:  Mohammad Mahdi Forghanifard; Elham Emami Vahid; Ezzat Dadkhah; Mehran Gholamin; Samaneh Broumand Noghabi; Martha Ghahraman; Mehdi Farzadnia; Mohammad Reza Abbaszadegan
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699

Review 5.  RNF6 as an Oncogene and Potential Therapeutic Target-A Review.

Authors:  Paweł Zapolnik; Antoni Pyrkosz
Journal:  BioTech (Basel)       Date:  2020-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.